MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
about
Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylationMolecular architecture of quartet MOZ/MORF histone acetyltransferase complexesMOZ and MORF, two large MYSTic HATs in normal and cancer stem cellsMusashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaRegulation of chromatin by histone modificationsDevelopment of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) miceThe homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesisThe Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells.New Developments in Chronic Myeloid Leukemia: Implications for TherapyDNA Methylation and Chromatin Remodeling: The Blueprint of Cancer EpigeneticsDifferentiation and transdifferentiation potentials of cancer stem cellsStem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic LeukemiaMolecular mechanisms for survival regulation of chronic myeloid leukemia stem cellsIn vivo molecular imaging of cancer stem cellsAcute myeloid leukaemia: a paradigm for the clonal evolution of cancer?It takes two to tango, a dance between the cells of origin and cancer stem cells in the Drosophila larval brainClonal evolution in hematological malignancies and therapeutic implicationsOncogenic Kras initiates leukemia in hematopoietic stem cellsAtopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skinStructure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity.Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1Structure of the AML1-ETO NHR3-PKA(RIIα) complex and its contribution to AML1-ETO activityThe double PHD finger domain of MOZ/MYST3 induces -helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modificationUpdate on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunitiesModeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft ModelsRegulation of KAT6 Acetyltransferases and Their Roles in Cell Cycle Progression, Stem Cell Maintenance, and Human Diseasep53 Acetylation: Regulation and ConsequencesThe Role of Histone Acetyltransferases in Normal and Malignant HematopoiesisMOZ is essential for maintenance of hematopoietic stem cellsMonocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cellsTumour heterogeneity and cancer cell plasticityGeneration of breast cancer stem cells through epithelial-mesenchymal transitionTargeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.Flow-cytometric phosphoprotein analysis reveals agonist and temporal differences in responses of murine hematopoietic stem/progenitor cellsEffect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromeReciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.The therapeutic promise of the cancer stem cell concept.Niche-based screening identifies small-molecule inhibitors of leukemia stem cellsZebrafish as a model for cancer self-renewalHsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
P2860
Q24298234-D4E99901-4CEF-4A6C-9712-C4D3B8960D26Q24312967-C23FAA89-17B5-4976-809B-0331ED7522AAQ24570117-158C2BE7-78A7-4549-B824-D6BF466DF292Q24597256-EB7284D6-C86F-47B9-A533-749241CA4C4EQ24635070-9C59FB44-D628-4684-99F3-A7FA417C126DQ24669724-09852A50-A5E5-4EC9-90E9-42B6F59DCF08Q24683173-51C1C32D-AC1A-4A7F-9704-2D8A2E37D960Q24811898-16C52C5E-1A46-4B0C-A80A-9D3FCB20F2C2Q26745669-08B8B2FD-3C33-4244-9234-B9FF45DDA598Q26749421-7DC86D94-D4A1-4502-8FD0-DDE7566E7263Q26782242-AB034A65-4E6A-453E-AD4D-03AAB0B40130Q26799954-4BE0CF35-6B39-44E8-9FD8-4E3A4B735E71Q26828528-5DD84DFA-46E7-47FD-AD04-6670212824D1Q26828630-44E58677-30DF-4D87-A9DA-A58CF7045C4DQ26828997-3F3D9E21-6E48-40E6-B115-C1A16B655BF3Q26864457-2741BA32-0A61-4DAB-8FCF-9DDAC8FB9D15Q27027655-D55EED9E-6084-4D34-984F-C865E41B8FE6Q27331698-F6042F86-D636-4885-83BF-2664675B8C17Q27334347-35FFE667-B26C-4C12-A22D-B7BAF9F3E1C5Q27653703-5DD68F4D-D9D2-413A-8A35-E5E88ACE4401Q27660605-945070F4-93EC-4A35-B2FC-69161338FDC7Q27664050-C2BB49C6-C680-4E31-B128-17D6FB2C80D9Q27680427-02622549-3672-4C28-8948-267E7F60B0F3Q28071384-DCBBF2D8-2C2C-4784-9C62-0BA7F1CD783CQ28076328-1A4F7C2C-F3D8-478F-B8B7-302DE9B8D6DFQ28079704-35DA4647-4F11-4F4F-834E-18B594C56E8FQ28085076-50154C27-ED80-4071-9260-01FBE431F4AAQ28088295-67BBDB5A-97AE-4D64-9084-059B736203F7Q28587906-9F588D16-450D-4B02-AE85-EE9F38D8D3A9Q28590949-20C8C43E-E2E1-4947-AFE7-3B89E65D8E67Q29617990-7974AF48-DAEE-48B2-931F-6F7FC6CCCD57Q29619717-1AF8113E-4F6F-46EC-8CAF-55AD6C4A41FCQ33292152-BCDFBB4C-40AB-48A2-9FA3-599E16774DD1Q33385651-8B2E6163-2011-4F6A-BA15-A789B21F0FC4Q33385999-854808CE-A84D-4590-9E6F-E6520C85AF97Q33513975-30AC8A32-132D-4E61-9E9C-1D2CA90379D0Q33559711-08C10DC9-56AB-4F93-94E8-2125062E6713Q33563509-13EC5780-3421-432D-B625-F625534627D7Q33584755-CC92173D-D615-482C-85B5-AF00BD6EFD27Q33611301-70EECB60-16F3-409C-9DE6-7EC45D1AADCA
P2860
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
MOZ-TIF2, but not BCR-ABL, con ...... ine hematopoietic progenitors.
@en
MOZ-TIF2, but not BCR-ABL, con ...... ine hematopoietic progenitors.
@nl
type
label
MOZ-TIF2, but not BCR-ABL, con ...... ine hematopoietic progenitors.
@en
MOZ-TIF2, but not BCR-ABL, con ...... ine hematopoietic progenitors.
@nl
prefLabel
MOZ-TIF2, but not BCR-ABL, con ...... ine hematopoietic progenitors.
@en
MOZ-TIF2, but not BCR-ABL, con ...... ine hematopoietic progenitors.
@nl
P2093
P1433
P1476
MOZ-TIF2, but not BCR-ABL, con ...... rine hematopoietic progenitors
@en
P2093
Benjamin H Lee
D Gary Gilliland
David Curley
Hirokazu Shigematsu
Kenji Deguchi
Koichi Akashi
Nicky Duclos
Rebecca Rowan
Shinichi Mizuno
Sonia Amaral
P304
P356
10.1016/J.CCR.2004.10.015
P577
2004-12-01T00:00:00Z